We are entrepreneurs at heart and are passionate about building world-class biotechnology companies. Our team consists of talented entrepreneurs that combine a deep knowledge of scientific research, product development, and business development to help position breakthrough science for success. Our passion is your power and we put our insight, experience, and expertise to work in helping you to achieve your goals.
Thong Q. Le
Chief Executive Officer
Dr. Kendall Mohler
Chief Development Officer
Ian A.W. Howes
Chief Financial Officer
David M. Schubert
Chief Operating Partner
Suzanne Rettenmier
Controller
Dr. Jonathan Mandelbaum
Principal
Dr. Alice Chen
Vice President
Jessica Burback
Senior Director of Operations & HR
Our Directors have extensive expertise in the biotechnology and pharmaceutical industries, and they know from personal experience what it takes to finance and operate a successful life science company. They believe in the power of innovative science to radically improve human health and are dedicated to supporting us in our mission to turn today’s scientific discoveries into tomorrow’s breakthrough products.
Dr. Bruce Carter
Director
Dr. Barbara J. Dalton
Pfizer Ventures
M. Johnston Erwin, Jr.
Eli Lilly and Company
Dr. Steven Gillis
ARCH Venture Partners
Dr. David Hirsh
Director
Dr. Leroy Hood
Director
Sundar Kodiyalam
Director
Thong Q. Le
Accelerator Life Science Partners
Joel S. Marcus
Alexandria Real Estate Equities Inc.
Alexandria Venture Investments
Dr. James P. Sullivan
AbbVie
Dr. Asish K. Xavier
Johnson & Johnson Development Corporation
Dr. Tadataka Yamada
Director
Our Operating Partners leverage their years of experience in specific areas of expertise to identify new investment areas and specific company-building opportunities. They also support the management and scientific oversight of our portfolio companies, helping you to reach your innovative potential.
Andrew Howard, Ph.D.
(New York, NY)
Wendy S. Johnson
(San Diego, CA)
David L. Pompliano, Ph.D.
(New York, NY)
Francisco D. Salva
(Philadelphia, PA)
John T. Santini, Jr., Ph.D.
(Minneapolis, MN)
David M. Schubert
(New York, NY)
Christopher Toombs, Ph.D.
(Seattle, WA)
Court R. Turner, J.D.
(San Diego, CA)
Transforming a breakthrough scientific idea into an innovative product takes more than robust data. Our clinical and scientific advisors support the complete spectrum of product development activities, providing critical insights into preclinical research, clinical trial design and strategy and regulatory pathways.
Lee E. Babiss, Ph.D.
John Latham, Ph.D.
George L. McLendon, Ph.D.
Kendall M. Mohler, Ph.D.
Gerald T. Nepom, M.D., Ph.D.
Homer L. Pearce, Ph.D.
Anil K. Singhal, Ph.D.
